PUERTO RICO DRUG ABUSE RESEARCH DEVELOPMENT PROGRAM

波多黎各药物滥用研究发展计划

• 批准号: 6145726
• 负责人: Rafaela R Robles
• 金额: $ 63.44万
• 依托单位: UNIVERSIDAD CENTRAL DEL CARIBE
• 依托单位国家: 美国
• 财政年份: 2000
• 资助国家: 美国
• 起止时间: 2000-08-01 至 2005-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6145726
• 关键词: HIV infections; behavioral /social science research tag; drug abuse; substance abuse related behavior

The Universidad Central de Caribe (UCC) School of Medicine in Bayamon, Puerto Rico, seeks support for a Minority Drug Abuse Research Development Program in response to the National Institute on Drug Abuse (NIDA) Initiative for Minority Institutions (MIDARDP, PD No. PAR 98-0001). The proposed Puerto Rico Drug Abuse Research Development Program (PRDARDP) will focus on developing an infrastructure, and the necessary environment and resources, at the UCC School of Medicine to train Puerto Rican (Latino) researchers in understanding drug abuse and its medical, social and psychological consequences, with particular emphasis on HIV/AIDS. During the first five years, the proposed PRDARDP will focus on training program participants from the biomedical and behavioral sciences, following a general theme: The medical, social and psychological consequences of drug abuse, with a focus on the HIV/AIDS epidemic. Our initial focus will be with the outcomes of drug abuse, not its antecedents. The individual research projects proposed in the PRDARDP will address three critical issues of this theme: HIV risk behaviors; effects of drug use on the immunology system and patterns of health care among HIV seronegative and seropositive drug abusers. The structure of the PRDARDP comprises three cores: Administrative, Research and Methodology, and Training cores. The training curriculum is extensive in content and structure, addressing the different components of the drug abuse and HIV/AIDS research fields. Our goal is to have the PRDARDP evolve into a training resource for Puerto Ricans and other Latinos in the US as well as in the South and Central America.

位于波多黎各巴亚蒙的加勒比大学(UCC)医学院寻求支持少数群体药物滥用研究发展方案，以响应国家药物滥用问题研究所(NIDA)针对少数群体机构的倡议(MIDARDP，PD No.标准杆98-0001)。拟议的波多黎各药物滥用研究发展方案(PRDARDP)将侧重于在UCC医学院建立基础设施以及必要的环境和资源，以培训波多黎各(拉丁裔)研究人员了解药物滥用及其医学、社会和心理后果，特别是艾滋病毒/艾滋病。在头五年，拟议的PRDARDP将重点培训生物医学和行为科学的项目参与者，遵循一个总的主题：药物滥用的医学、社会和心理后果，重点是艾滋病毒/艾滋病流行。我们最初的重点将是药物滥用的后果，而不是其前因后果。PRDARDP中提出的个人研究项目将解决这一主题的三个关键问题：艾滋病毒危险行为；药物使用对免疫系统的影响；艾滋病毒血清阴性和血清阳性吸毒者的卫生保健模式。PRDARDP的结构包括三个核心：行政、研究和方法以及培训核心。培训课程内容和结构广泛，涉及药物滥用和艾滋病毒/艾滋病研究领域的不同组成部分。我们的目标是使PRDARDP发展成为波多黎各人和其他拉美人在美国以及南美洲和中美洲的培训资源。